Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Lexicon Pharmaceuticals (LXRX) Assets Average (2023 - 2025)

Lexicon Pharmaceuticals (LXRX) has disclosed Assets Average for 5 consecutive years, with $195.5 million as the latest value for Q4 2025.

  • On a quarterly basis, Assets Average fell 36.9% to $195.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $195.5 million, a 36.9% decrease, with the full-year FY2025 number at $241.7 million, down 8.42% from a year prior.
  • Assets Average was $195.5 million for Q4 2025 at Lexicon Pharmaceuticals, down from $215.8 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $395.3 million in Q2 2024 to a low of $195.5 million in Q4 2025.
  • A 3-year average of $283.0 million and a median of $279.1 million in 2023 define the central range for Assets Average.
  • Peak YoY movement for Assets Average: skyrocketed 64.9% in 2024, then tumbled 37.87% in 2025.
  • Lexicon Pharmaceuticals' Assets Average stood at $253.0 million in 2023, then grew by 22.46% to $309.8 million in 2024, then tumbled by 36.9% to $195.5 million in 2025.
  • Per Business Quant, the three most recent readings for LXRX's Assets Average are $195.5 million (Q4 2025), $215.8 million (Q3 2025), and $261.6 million (Q2 2025).